| [1]Brnemark PI.Osseointegration and its experimental background[J].J Prosthet Dent,1983,50(3):399-410[2]Urist MR,Lietze A,Mizutani H,et al.A bovine low molecular weight bone morphogenetic protein (BMP) fraction[J].Clin Orthop Relat Res,1982,(162):219-32[3]王翔,杨连甲.钛种植体复合骨形成蛋白的初步实验研究[J].实用口腔医学杂志,1989,5(4):245-247[4]Urist MR,Lietze A,Dawson E.Betatricalcium phosphate delivery system for bone morphogenetic protein[J].Clin Orthop Relat Res,1984,(187):277-280[5]Brnemark PI,Hansson BO,Adell R,et al.Osseointegrated implants in the treatment of the edentulous jawExperience from a 101977 period[J].. Scand J Plast Reconstr Surg Suppl,1977,16(1):1-132[6]〓刘宝林.口腔种植学［M］. 北京: 人民卫生出版社,2011:6-24.[7]Carlisle E,Fischgrund JS.Bone morphogenetic proteins for spinal fusion[J].Spine J,2005,5(6 Suppl):240-S[8]Urist MR.Bone: formation by autoinduction1965[J].. Clin Orthop,2002,150(395):4-10[9]〓柏树令,顾晓松,张传森.组织工程学教程 ［M］. 北京: 人民军医出版社,2009:61.[10]李唐新,郑林卿,王大章,等.非血管化骨-人重组骨形成蛋白2复合种植体同期移植的超微结构观察[J].中国口腔颌面外科杂志,2005,3(3):183-188[11]Hoffmann A,Weich HA,Gross G,et al.Perspectives in the biological function,the technical and therapeutic application of bone morphogenetic proteins[J].Appl Microbiol Biotechnol,2001,57(3):294-308[12]王非,刘宝林.羟基磷灰石涂层多晶氧化铝陶瓷牙种植体复合骨形成蛋白的实验[J].解放军医学杂志,1995,20(5):330-332[13]Jin QM,Takita H,Kohgo T,et al.Effects of geometry of hydroxyapatite as a cell substratum in BMPinduced ectopic bone formation[J].J Biomed Mater Res,2000,51(3):491-499[14]Liu Y,De Groot K,Hunziker EB.BMP2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model[J].Bone,2005,36(5):745-757[15]Liu Y,Hunziker EB,Layrolle P,et al.Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity[J].T1/2 Eng,2004,10(1/2):101-108[16]Kasemo B.Biocompatibility of titanium implants: surface science aspects[J].J Prosthet Dent,1983,49(6):832-837[17]Thorey F,Menzel H,Lorenz C,et al.Enhancement of endoprosthesis anchoring using BMP2[J].Technol Health Care,2010,18(3):217-229[18]Adden N,Gamble LJ,Castner DG,et al.Phosphonic acid monolayers for binding of bioactive molecules to titanium surfaces[J].Langmuir,2006,22(19):8197-8204[19]Voggenreiter G,Hartl K,Assenmacher S,et al.Assesment of the biological activity of chemically immobilized rhBMP2 on titanium surfaces in vivo[J].Materialwissenschaft Werkstofftechnik,2001,32(12):942-948[20]Huh JB,Park CK,Kim SE,et al.Alveolar ridge augmentation using anodized implants coated with Escherichia coliderived recombinant human bone morphogenetic protein 2[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2011,112(1):42-49[21]张达江,王亮.Ⅰ型胶原蛋白的结构、功能及其应用研究的现状与前景[J].生物技术通讯,2006,17(2):265-269[22]Okubo Y,Bessho K,Fujimura K,et al.Osteogenesis by recombinant human bone morphogenetic protein2 at skeletal sites[J].Clin Orthop Relat Res,2000,(375):295-301[23]〖WB〗He J,Huang T,Gan L,et al.Collageninfiltrated porous hydrox[24]〖DW〗yapatite coating and its osteogenic properties: in vitro and in vivo study ［J］.J Biomed Mater Res A,2012,100(7): 1706-1715.[25]杨军,邓红镭.复合bmp钛种植体植入放疗颌骨后骨愈合的观察[J].第三军医大学学报,1999,21(11):861-863[26]Jiang QH,Liu L,Shen JW,et al.Influence of multilayer rhBMP2 DNA coating on the proliferation and differentiation of MC3T3E1 cells seeded on roughed titanium surface[J].J Biomed Mater Res A,2012,100(10):2766-2774[27]贾骏,段嫄嫄,张少锋,等.纯钛表面PPy/rhBMP2复合涂层对骨髓间充质干细胞增殖、分化的影响[J].稀有金属材料与工程,2006,35(12):1879-1883[28]Shiels S,Oh S,Bae C,et al.Evaluation of BMP2 tethered polyelectrolyte coatings on hydroxyapatite scaffolds in vivo[J].J Biomed Mater Res B Appl Biomater,2012,100B(7):1782-1791[29]张承焱.医用高分子材料的应用研究及发展[J].中国医疗器械信息,2005,11(5):35-38[30]田怡,钱欣.聚乳酸的结构、性能与展望[J].石化技术与应用,2006,24(3):233-237[31]Yoneda M,Terai H,Imai Y,et al.Repair of an intercalated long bone defect with a synthetic biodegradable boneinducing implant[J].Biomaterials,2005,26(25):5145-5152[32]于婷,刘娅,王宇,等.改性纳米羟基磷灰石/Plga复合材料的制备及生物活性[J].高等学校化学学报,2009,30(7):1439-1444[33]Ji Y,Xu GP,Yan JL,et al.Transplanted bone morphogenetic protein/poly(lacticcoglycolic acid) delayedrelease microcysts combined with rat micromorselized bone and collagen for bone t4 engineering[J].J Int Med Res,2009,37(4):1075-1087[34]Ramazanoglu M,Lutz R,Rusche P,et al.Bone response to biomimetic implants delivering BMP2 and VEGF: An immunohistochemical study ［J］. J Craniomaxillofac Surg. 2013 Feb 21［20130401］. pii: S10105182(13)00053X. doi: 10.1016/j.jcms.2013.01.037.[35]Strobel C,Bormann N,KadowRomacker A,et al.Sequential release kinetics of two (gentamicin and BMP2) or three (gentamicin,IGFI and BMP2) substances from a onecomponent polymeric coating on implants[J].J Control Release,2011,156(1):37-45[36]Keller S,Nickel J,Zhang JL,et al.Molecular recognition of BMP2 and BMP receptor IA[J].Nat Struct Mol Biol,2004,11(5):481-488[37]Albers CE,Hofstetter W,Sebald HJ,et al.L51P A BMP2 variant with osteoinductive activity via inhibition of Noggin[J].Bone,2012,51(3):401-406[38]Sebald HJ,Klenke FM,Siegrist M,et al.Inhibition of endogenous antagonists with an engineered BMP2 variant increases BMP2 efficacy in rat femoral defect healing[J].Acta Biomater,2012,8(10):3816-3820 |
